H.R. 9755, Biotechnology Diplomatic Infrastructure. Quorum's AI analysis reads it as a trade-off: gains for some, costs for others.
H.R. 9755 · Mixed
What it does
This bill creates a new position at the State Department called the Senior Biotechnology Official, to be appointed within 90 days. The official will coordinate U.S. diplomatic efforts on biotechnology, including supply-chain security, international research partnerships, data-sharing agreements, and capacity-building with allied nations—essentially making biotechnology a formal diplomatic priority alongside traditional foreign policy.
The analysis names pharmaceutical companies (BMY, PFE, JNJ, GH, DVA) — and 2 more groups — among the beneficiaries.
The trade-off
The bill grants the Secretary of State broad discretion to assign 'any other duties' to the new official, creating potential for mission creep or undefined responsibilities without further congressional oversight.
Transparency scores 45%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Rich McCormick. Cosponsored by Ami Bera.